Solvay increases hydroquinone production

SOLVAY will raise its hydroquinone production capacity by 20% at its plant in Saint-Fons, France.

Hydroquinone is used for monomer inhibition and in polymer and coating applications. “Solvay is committed to serve its customers’ long-term growing needs in all major regions and this new capacity increase in Europe will allow [us] to continue to reliably supply our full range of monomer inhibitors,” said Peter Browning, President of Solvay’s Aroma Performance GBU. 

The expansion at the Saint-Fos site is due to be fully operational in the second quarter of 2019.

Solvay also recently increased its capacity at its site in Zhenjiang, China. The plant in France is one of three that make up Solvay’s global inhibitor production network. The plants produce MEHQ (monomethyl ether of hydroquinone), TBC (tertiary butyl-catechol), and PTZ (phenothiazine), as well as hydroquinone.